Foster City · Series B–Late Stage · 17 people tracked
Find your way into Gilead Sciences
409 people in our graph share verified history with the Gilead Sciences team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Gilead's research and development approach centers on pursuing transformative medicines and cures across three therapeutic areas: virology, oncology and inflammation. Drawing on a 35-plus-year track record, the company identifies best-in-class molecules, biologics, cell therapies and combinations and advances them quickly. It has helped turn public health challenges such as HIV and hepatitis C into manageable or curable conditions, and is developing therapies across viral hepatitis, SARS-CoV-2 and potential pandemic viruses. In oncology it seeks treatments offering long-term remission and cures, while in immunology it targets next-generation therapies for inflammatory and fibrotic diseases. The company set an ambition in 2019 to deliver 10-plus transformative therapies by 2030.
Source: firm website, verified Aug 16, 2026.
Team · 17 people
from the firm's website
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Healthtech ×3AI & Machine Learning ×2Deep Tech ×1Digital Health ×1Medical Devices ×1SaaS ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBy year:2023 · 12022 · 12 dated
Tizona Therapeutics is a biotechnology company developing first-in-class immuno-oncology therapeutics, including its lead clinical-stage asset TTX-080, aimed at changing cancer progression and relapse.
AI & Machine LearningBiotechHealthtech
Vijay K. Kuchroo(Scientific Co-Founder & Advisory Board Member)Drew Pardoll(Scientific Co-Founder & Advisory Board Member)Dario Vignali(Scientific Co-Founder & Advisory Board Member)Jedd Wolchok(Scientific Co-Founder & Advisory Board Member)Christine O'Brien(Chief Executive Officer & Board Member)inCourtney Beers(Chief Scientific Officer)
Co-investorsCanaan PartnersMPM BioImpactAbingworthAstellas Venture Management LLCLightstone Ventures
Curebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites.
AI & Machine LearningBiotechDigital HealthHealthtechSaaSFort Lauderdale, US
Storm Stillman(Chief Executive Officer)inTom Lemberg(Founder)in
Co-investorsAcrew CapitalBold Capital PartnersBreyer CapitalFuture Planet CapitalNotable CapitalXfund+6 more
BiotechWatertown, US
Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)
BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)
Co-investorsBill & Melinda Gates FoundationInvusKendall Capital PartnersPolaris Partners
Tentarix Biotherapeutics develops multifunctional biologics to modernize healthcare standards through precision medicine.
BiotechDeep TechHealthtechMedical Devices
BoardSrini Akkaraju(Director, Founder)Paul Kang(Director, Founder)
Co-investorsVersant VenturesSamsara BioCapital
BiotechPhiladelphia, US
Anne Chew(Director and President)
BoardKevin Mahoney(Director)
Co-investorsAndreessen HorowitzKleiner PerkinsLAVLilly Asia VenturesMilitia Hill Ventures
Portfolio news
latest coverage across their companiesTentarix · businesswire.com · Sep 30, 2025
Tmunity Therapeutics · whyy.org · Jul 10, 2025
Lyndra · endpoints.news · Mar 25, 2025
Frequently asked questions
- What stage does Gilead Sciences invest at?
- Gilead Sciences invests at the Series B, Series C, Late Stage stages.
- What sectors does Gilead Sciences focus on?
- Gilead Sciences focuses on Advanced Manufacturing, Biotech, Healthtech, SaaS.
- Where is Gilead Sciences located?
- Gilead Sciences is headquartered in Foster City, US.
Media · Podcasts & interviews
featuring the teamGilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history
CNBC Television · Daniel O’Day
Hear more from CEO Daniel O’Day about Gilead Sciences' investment in U.S. innovation.
PhRMA · Daniel O’Day
Watch CNBC's full interview with Gilead Sciences chairman and CEO Daniel O’Day
Daniel O’Day · cnbc.com
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
West Virginia Jobs Investment Trust is a publicly-funded venture capital provider that invests in eligible West Virginia businesses to support job creation and economic development within the state.